Literature DB >> 8467385

Transient increase in endogenous basic fibroblast growth factor in neurons of ischemic rat brains.

Y Kumon1, S Sakaki, O Kadota, S Matsuda, H Fujita, H Yoshimura, M Sakanaka.   

Abstract

An antiserum against basic fibroblast growth factor (bFGF) was shown to recognize an 18-kDa protein (possibly bFGF) in crude neocortical extracts by immunoblot and used to investigate the changes of bFGF immunoreactivity in neurons and astrocytes of the cerebral cortex of rats 1-21 days after unilateral occlusion of the middle cerebral artery (MCA). The mildly ischemic neocortex exhibited no signs of cell loss or degeneration in Nissl-stained sections 1-14 days after MCA occlusion, but it contained pyramidal cell bodies and processes with more intense bFGF immunoreactivity than did the control neocortex. bFGF immunoreactivity in the ischemic hemisphere gradually declined in intensity and by 21 days after MCA occlusion, it had reached the control level. On the other hand, there were many bFGF immunoreactive astrocytes in the primary olfactory cortex on the side of infarction. These findings suggest that MCA occlusion causes an increase in bFGF content not only in astrocytes but also in neurons, depending on the severity of the ischemic insult in individual cortical regions. The transient augmentation of bFGF expression or accumulation in mildly ischemic pyramidal neurons but not in astrocytes is in line with previous studies suggesting the neurotrophism of exogenously applied bFGF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467385     DOI: 10.1016/0006-8993(93)91369-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  The enhancement of growth and differentiation of rat adrenal nerve cells by the addition of conditioned medium from human fibroblast cultures.

Authors:  J S Hong; D S Kim; S H Kim; D H Choi; J H Lee; H Y Lee
Journal:  Cytotechnology       Date:  1998-03       Impact factor: 2.058

Review 2.  Strategies targeting endogenous neurogenic cell response to improve recovery following traumatic brain injury.

Authors:  Kaushal Patel; Dong Sun
Journal:  Brain Res       Date:  2016-02-08       Impact factor: 3.252

Review 3.  Biochemical and molecular characteristics of the brain with developing cerebral infarction.

Authors:  H Kato; K Kogure
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

Review 4.  Neural stem cell therapies and hypoxic-ischemic brain injury.

Authors:  Lei Huang; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2018-05-21       Impact factor: 11.685

5.  Increased basic fibroblast growth factor immunoreactivity in the brain of stroke-prone spontaneously hypertensive rats.

Authors:  H Kataoka; E Yamada; F Hazama
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

6.  Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury.

Authors:  Dong Sun; M Ross Bullock; Melissa J McGinn; Zhengwen Zhou; Nabil Altememi; Sarah Hagood; Robert Hamm; Raymond J Colello
Journal:  Exp Neurol       Date:  2008-11-27       Impact factor: 5.330

7.  Effect of an exo-polysaccharide from the culture broth of Hericium erinaceus on enhancement of growth and differentiation of rat adrenal nerve cells.

Authors:  Young Shik Park; Hyun Soo Lee; Moo Ho Won; Jin Ha Lee; Shin Young Lee; Hyeon Yong Lee
Journal:  Cytotechnology       Date:  2002-09       Impact factor: 2.058

8.  Ceruloplasmin deficiency reduces levels of iron and BDNF in the cortex and striatum of young mice and increases their vulnerability to stroke.

Authors:  Sarah J Texel; Jian Zhang; Simonetta Camandola; Erica L Unger; Dennis D Taub; Raymond C Koehler; Z Leah Harris; Mark P Mattson
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

9.  Ghrelin Ameliorates Traumatic Brain Injury by Down-Regulating bFGF and FGF-BP.

Authors:  Xuefei Shao; Qianxin Hu; Sansong Chen; Qifu Wang; Pengcheng Xu; Xiaochun Jiang
Journal:  Front Neurosci       Date:  2018-07-05       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.